Page 20 - Anjali Singh

USC seeks Indian collaborations to address healthcare challenges

India's efficient research systems and diverse population offer valuable opportunities for conducting impactful clinical trials

Tata Motors Group reports 1% growth in Q3 FY25 global wholesales

Global wholesales of Tata Motors' commercial vehicles, including the Tata Daewoo range, reached 97,535 units, reflecting a decline of 1 per cent compared to Q3 FY24

Lupin receives US FDA tentative approval for Ivacaftor Oral Granules

These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral Granules

Three-wheeler exports rebound in 2024 despite global economic challenges

This positive trend comes after consecutive years of decline, with exports falling by 26 per cent in FY23 and 17 per cent in FY24

Hyundai introduces new variants, features upgrades for popular models

The new offerings come at a time when Hyundai has recorded its highest-ever yearly domestic sales of 6,05,433 units

Lupin gets clearance from USFDA for its Pithampur manufacturing facility

Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets

Auto component companies focus on new markets, products as growth slows

According to a recent CRISIL report, while replacement demand will provide some support, export growth is expected to taper compared to the previous year

Two-wheeler sales a mixed bag in December, stay on growth path in 2024

Manufacturers like Royal Enfield, Suzuki saw double-digit rise in sales last month

Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

According to a regulatory filing with BSE, the agreement was signed on December 31, 2024, with the transaction expected to be completed by January 31, 2025

Electric two wheelers, premium bikes set to dominate market in 2025

Honda is expecting to kick off January 2025 with the highly anticipated launch of Activa e: and QC1 electric scooters

Lupin acquires Huminsulin from Lilly to strengthen diabetes portfolio

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and children

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Recent USFDA data reveals a decline in the number of adverse classification outcomes of inspections

Akums Group signs 200 million euro deal for European market expansion

The commercial supply of these products is expected to begin in 2027 and continue until 2032

Improved efficiency, demand help hospital chains make gains in 2024

Average revenue per occupied bed of major health care companies grows

EV-maker Greaves Electric Mobility files IPO papers, seeks Rs 1,000 crore

The IPO includes a fresh issue of equity shares worth Rs 1,000 crore and an offer-for-sale of up to 189.3 million equity shares by Greaves Cotton Limited and Abdul Latif Jameel Green Mobility Solution

Online pharmacy operating losses to reduce in FY26, predicts CRISIL

For e-pharmacies, this positive trajectory is being driven by a strategic pivot towards high-margin product segments, such as wellness items and medical equipment

Lohia Auto targets 300k sales by 2027 with new E3W brand 'Youdha'

Earlier, Lohia Auto had announced an investment of Rs 20 crore to support its expansion plans, which include both passenger and cargo electric vehicle models

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Record fundraising surpasses the previous high of Rs 9,370 cr in 2023

myTVS enters B2B qcom for automotive parts; promises 2 hour delivery

With a catalogue of over 12 million parts, myTVS will initially establish 50 "dark stores" branded as myTVS Hypermart by March 2025 in Tamil Nadu, Kerala, Maharashtra, and Gujarat

EV launches in India to double in 2025, SUVs dominate new lineups

Industry leaders such as Maruti Suzuki, Tata Motors, Mahindra & Mahindra, Hyundai, and MG Motors are gearing up to introduce a range of EVs in India